Priority Date: 10.08.10 (US 20100853610)

INJECTABLE PHARMACEUTICAL COMPOSITION FOR PREVENTING, STABILISING AND/OR INHIBITING PATHOLOGICAL NEOVASCULARIZATION-RELATED CONDITIONS

  • Application ID: EP11741232
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

Company dna icosa
no operation time available
708.16
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Icosa is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 187 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 10.08.2010 - Priority Date (US 20100853610)
  • 16.02.2012 - Publication A1 (WO2012020040)
  • 19.06.2013 - Publication A1 (EP2603588)